A leading global pharmaceutical company is looking for manufacturers who can supply or are developing Omalizumab and Dornase alpha formulations for the US market.

Reply

Comments :

bd@qbdbiosciences.com

Hi We have access to Omalizumab entering Phase-1 and Dornase in Phase-3 . Other recombinant and biosimlars are also available for US market for licensing. Please share details of your company on my email id.

14:53,  30 Nov 2018
Reply

hostrinlifesciences@gmail.com

Hii, we do support for the complete formulation development for the same with 3 lab,pilot & commercial batches.

For further requirements please feel free to contact me.

Best Regards,
Andrew P
CEO & MD,
Hostrin Life Sciences,
www.hostringlobal.com
andrew@hostringlobal.com

16:05,  06 Dec 2018
Reply